Ireland’s first one-stop webportal about development, manufacture, supply and adoption of advanced therapies.
Joined July 2022
- Tweets61
- Following14
- Followers25
- Likes0
LIfT BioSciences secures €12M from Ireland’s DTIF – the largest grant to date – to bring its IMAN neutrophil therapy into first-in-human cancer trials in Galway by 2026. Read more: atmp.ie/lift-biosciences-sec…
#CancerResearch #Biotech #Immunotherapy #Ireland #LifeSciences #Innovation
Join 500 senior decision-makers at Advanced Therapies Europe 2025 in Barcelona. Tickets available now - places are limited. As a valued member of the ATMP.ie community, you now have exclusive access to a 20% discount code: ATMPIE20.
atmp.ie/advanced-therapies-e…
FDA has removed the REMS requirement for all approved BCMA- & CD19-directed CAR-T cell therapies - cutting barriers to treatment & expanding access for patients, especially in underserved areas. atmp.ie/fda-removes-rems-req…
#CART #FDA #Oncology
🇮🇪 Ireland is going big on advanced therapies.
With bold moves in R&D, manufacturing & patient access, it's aiming for 1,000 ATMP-treated patients/yr by 2034.
A rising global contender. atmp.ie/ireland-positions-it…
#ATMP #Biotech #Ireland #TranslationalMedicine
🚀 Ireland launches the ARC Hub for Therapeutics — a bold step to fast-track biomedical research into real-world treatments.
atmp.ie/the-arc-hub-for-ther…
@tcddublin @RCSI_Irl @ucddublin #TranslationalResearch #ARCProgramme #AdvancedTherapies
🔬 New from @UCC: mRNA delivery beyond the liver?
Researchers explored how tweaking amino-polyester side chains impacts mRNA-loaded nanoparticles—showing promise for safer, more targeted delivery to non-liver tissues. atmp.ie/breakthrough-in-poly…
#mRNA #ATMP
Why is a strong Contamination Control Strategy (CCS) essential in ATMP manufacturing?
Patrick Nieuwenhuizen from PharmaLex explains how risk-based planning, training & sterile practices protect product quality.
atmp.ie/contamination-contro…
#ATMP #GMP
Upcoming GENEGUT Seminar (Free & Online)
📅 5 June 2025 | 🕒 15:00–16:00 IST (UTC+1)
Dr. Ameya Kirtane (Univ. of Minnesota) will explore GI delivery of #mRNA therapeutics
🎤 Hosted by @GENEGUT_EU & @Pharmacy_UCC
🔗 Register: atmp.ie/genegut-seminar-seri…
€17M in DTIF funding announced — incl. €10.7M for Can-Vas, a pioneering placental cell therapy to treat newborn brain injuries.
Led by HAON Life Sciences with NIBRT, HiTech Health & UCC.
📖 atmp.ie/ireland-backs-cuttin…
#DTIF #Innovation #Biotech #CellTherapy
31-year-old Stuart Haxell regains his sight after receiving Luxturna, the first gene therapy for inherited retinal disease, at Mater Hospital.
📰 Full story: atmp.ie/first-use-of-luxturn…
#GeneTherapy #Luxturna #RareDiseases #VisionRestored #ATMP
NIBRT PI Prof. Mark Smales secures €3.5M+ through the Taighde Éireann Award to advance biotherapeutic manufacturing. His research will focus on gene therapy, RNA therapeutics, and bioprocess engineering. Read more atmp.ie/nibrt-pi-mark-smales…
Exosomes Europe 5-6 June, London - Special £499 rate for ATMP.ie members expires Friday atmp.ie/exosomes-europe/
UCC and NIBRT Officially Launch a Unique Partnership on May 3, 2024 atmp.ie/ucc-and-nibrt-offici…
Navigating the Road to a Successful Annex 1 Inspection - 9th of May 2024@NIBRT atmp.ie/navigating-the-road-…
HiTech Health: A New GMP-Compliant Facility in Galway for Manufacturing Cell and Gene Therapies
atmp.ie/hitech-health-a-new-…
Maynooth Researchers Publish Report on ‘Access and Provision of CAR-T Therapies in Ireland’ Calling for National Strategy atmp.ie/maynooth-researchers…
Trinity College and NIBRT Researcher Awarded SFI Funding for Project Focused on Improving the Manufacturing of Cell Therapies
atmp.ie/trinity-college-and-…
A brief overview of how robotics are trying to solve the CGT manufacturing bottleneck. atmp.ie/robotics-in-cgt-manu…
Connect with ATMP.ie and NIBRT at the CGT EU Conference in Dublin, 4-7th December 2023.
atmp.ie/nibrt-speaking-at-cg…